000			02016 a2200613 4500
005			20250517183946.0
264		0	_c20190204
008			201902s 0 0 eng d
022			_a1432-0843
024	7		_a10.1007/s00280-017-3459-6 _2doi
040			_aNLM _beng _cNLM
100	1		_aEmadi, Ashkan
245	0	0	_aAsparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemia. _h[electronic resource]
260			_bCancer chemotherapy and pharmacology _c01 2018
300			_a217-222 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aAsparaginase _xadministration & dosage
650	0	4	_aDickeya chrysanthemi _xenzymology
650	0	4	_aFemale
650	0	4	_aGlutamine _xblood
650	0	4	_aHumans
650	0	4	_aLeukemia, Myeloid, Acute _xblood
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aRecurrence
650	0	4	_aRemission Induction
650	0	4	_aYoung Adult
700	1		_aLaw, Jennie Y
700	1		_aStrovel, Erin T
700	1		_aLapidus, Rena G
700	1		_aJeng, Linda J B
700	1		_aLee, Myounghee
700	1		_aBlitzer, Miriam G
700	1		_aCarter-Cooper, Brandon A
700	1		_aSewell, Danielle
700	1		_aVan Der Merwe, Isabella
700	1		_aPhilip, Sunita
700	1		_aImran, Mohammad
700	1		_aYu, Stephen L
700	1		_aLi, Hongxia
700	1		_aAmrein, Philip C
700	1		_aDuong, Vu H
700	1		_aSausville, Edward A
700	1		_aBaer, Maria R
700	1		_aFathi, Amir T
700	1		_aSingh, Zeba
700	1		_aBentzen, Søren M
773	0		_tCancer chemotherapy and pharmacology _gvol. 81 _gno. 1 _gp. 217-222
856	4	0	_uhttps://doi.org/10.1007/s00280-017-3459-6 _zAvailable from publisher's website
999			_c27770065 _d27770065